Showing results (41-50 of 71) with videos related to
Sort By:
Pageof 8
Life Sciences|May 26, 2005
Antioxidant treatment normalizes nitric oxide production, renal sodium handling and blood pressure in experimental hyperleptinemiaJerzy Beltowski, Grazyna Wójcicka, Anna Jamroz-Wiśniewska, et al.Life Sciences|July 20, 2010
The differentiating effect of glimepiride and glibenclamide on paraoxonase 1 and platelet-activating factor acetylohydrolase activityGrazyna Wójcicka, Anna Jamroz-Wiśniewska, Andrzej Marciniak, et al.Acta Biochimica Polonica|September 28, 2004
Bidirectional regulation of renal cortical Na+,K+-ATPase by protein kinase CJerzy Bełtowski, Andrzej Marciniak, Anna Jamroz-Wiśniewska, et al.Annals of Agricultural and Environmental Medicine : AAEM|September 30, 2025
IRIS without PML in MS patients - a case report of IRIS after past alemtuzumab therapy with subsequent oral cladribine treatment and review of the literatureAnna Jamroz-Wiśniewska, Anna Drelich-Zbroja, Urszula Chyrchel-Paszkiewicz, et al.Biochemical Pharmacology|February 20, 2008
Transactivation of epidermal growth factor receptor in vascular and renal systems in rats with experimental hyperleptinemia: role in leptin-induced hypertensionAnna Jamroz-Wiśniewska, Grazyna Wójcicka, Ewelina Łowicka, et al.Pharmacological Research|February 11, 2014
Nucleoside monophosphorothioates as the new hydrogen sulfide precursors with unique propertiesJerzy Bełtowski, Andrzej Guranowski, Anna Jamroz-Wiśniewska, et al.Life Sciences|January 22, 2008
Role of extracellular signal-regulated kinases (ERK) in leptin-induced hypertensionGrazyna Wójcicka, Anna Jamroz-Wiśniewska, Sylwia Widomska, et al.Molecular and Cellular Biochemistry|August 12, 2008
Renal antioxidant enzymes and glutathione redox status in leptin-induced hypertensionJerzy Bełtowski, Anna Jamroz-Wiśniewska, Grazyna Wójcicka, et al.Neurologia I Neurochirurgia Polska|May 31, 2008
Tumour-like lesions in multiple sclerosisAnna Jamroz-Wiśniewska, Marzena Janczarek, Ewa Belniak, et al.Oxidative Medicine and Cellular Longevity|April 8, 2020
Cladribine Treatment Improved Homocysteine Metabolism and Increased Total Serum Antioxidant Activity in Secondary Progressive Multiple Sclerosis PatientsAnna Jamroz-Wiśniewska, Jerzy Bełtowski, Grażyna Wójcicka, et al.Pageof 8